Sodium, potassium and glucose management in organ transplantation.
Keegan
Mark T
MT
Division of Critical Care, Department of Anesthesiology, Mayo Clinic and Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. keegan.mark@mayo.edu
Wright
David R
DR
D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism*; D005440:Fluid Therapy; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D006947:Hyperkalemia / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D007003:Hypoglycemia / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007010:Hyponatremia / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D016377:Organ Transplantation / Q000009:adverse effects; D019990:Perioperative Care; D011188:Potassium / Q000097:blood*; D012964:Sodium / Q000097:blood*; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D065092:Antidiuretic Hormone Receptor Antagonists; D001552:Benzazepines; D015415:Biomarkers; D001786:Blood Glucose; D007004:Hypoglycemic Agents; C106389:conivaptan; D012964:Sodium; D011188:Potassium